Compounds > glucagon
Page last updated: 2024-09-04

glucagon and bay-k-8644

glucagon has been researched along with bay-k-8644 in 4 studies

Compound Research Comparison

Studies
(glucagon)		Trials
(glucagon)		Recent Studies (post-2010)
(glucagon)		Studies
(bay-k-8644)		Trials
(bay-k-8644)		Recent Studies (post-2010) (bay-k-8644)
26,0391,4983,0542,5550144

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marco, J; Miralles, P; Monge, L; Peiró, E; Silvestre, RA; Villanueva, ML1
Raue, F; Scherübl, H; Ziegler, R; Zopf, G1
Bataille, D; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D1
Gaisano, HY; MacDonald, PE; Salapatek, AM; Wheeler, MB1

Other Studies

4 other study(ies) available for glucagon and bay-k-8644

ArticleYear
In vitro effects of BAY K 8644, a dihydropyridine derivative with hypoglycaemic properties, on hepatic glucose production and pancreatic hormone secretion.
    Biochemical pharmacology, 1988, Aug-01, Volume: 37, Issue:15

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Glucagon; Gluconeogenesis; Glucose; Glycogen; Insulin; Insulin Secretion; Liver; Male; Pancreas; Pancreatic Hormones; Perfusion; Rats; Rats, Inbred Strains; Somatostatin

1988
Calcitonin secretion and cyclic AMP-efflux from C-cells, stimulated by glucagon and either calcium or Bay K 8644.
    Hormone and metabolic research. Supplement series, 1989, Volume: 21

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcitonin; Calcium; Carcinoma; Cell Line; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Rats; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured

1989
Miniglucagon: a local regulator of islet physiology.
    Annals of the New York Academy of Sciences, 1998, Dec-11, Volume: 865

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Peptides

1998
Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Molecular endocrinology (Baltimore, Md.), 1999, Volume: 13, Issue:8

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcium Channel Agonists; Cell Line; Cyclic AMP; Electric Conductivity; Gene Deletion; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Mutagenesis; Peptide Fragments; Protein Precursors; Rats; Receptors, Glucagon; Structure-Activity Relationship; Transfection

1999